SpectRx, Inc.
6025A Unity Drive
Norcross
Georgia
30071
United States
Tel: 770-242-8723
Fax: 770-242-8639
Email: skillen@spectrx.com
20 articles about SpectRx, Inc.
-
SpectRx, Inc. Completes Name Change to Guided Therapeutics, Inc. Receives New Stock Ticker Symbol - GTHP
5/8/2008
-
SpectRx, Inc. Signs Agreement to Manufacture and Supply New Non-invasive Cancer Detection Devices
11/27/2007
-
SpectRx, Inc. Reports Third Quarter 2007 Results
11/20/2007
-
SpectRx, Inc.: New Painless Test for Cervical Cancer Begins Key Segment of FDA Clinical Trial at the University of Miami
5/17/2007
-
SpectRx, Inc. Taps Faupel as CEO
5/14/2007
-
SpectRx, Inc. Provides Update on Ticker Symbol
5/1/2007
-
SpectRx, Inc.'s Light-Based Cervical Cancer Test Promising
4/26/2007
-
SpectRx, Inc. CEO to Retire
4/16/2007
-
SpectRx, Inc. Signs Letter of Intent to Sell SimpleChoice Insulin Infusion Set Business
3/20/2007
-
SpectRx, Inc. Announces Planned Reorganization; Focus on Cervical Cancer Detection
3/15/2007
-
SpectRx, Inc. Holds Pre-PMA Meetings With FDA On Painless Cervical Cancer Test
1/30/2007
-
SpectRx, Inc. Announces Management Changes
1/17/2007
-
SpectRx, Inc. Release: Painless Cancer Test May Eliminate Half Of Unnecessary Cervical Biopsies
1/10/2007
-
SpectRx, Inc. Provides Update On Ticker Symbol
12/26/2006
-
SpectRx, Inc. Director Chris Monahan Retires
10/10/2006
-
SpectRx, Inc. Provides Update On Ticker Symbol
9/25/2006
-
SpectRx, Inc. Reports First Quarter 2006 Results
5/23/2006
-
SpectRx, Inc. Schedules Date For Release Of First Quarter 2006 Results
5/19/2006
-
SpectRx, Inc. Successfully Builds And Tests First Pre-Production Non-Invasive Cervical Cancer Detection Device
1/4/2006
-
Drug Patches In Pipeline For Diabetes, Depression
4/21/2004